Neighborhood-level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
Gillian C GoobieChristopher J RyersonKerri A JohannsonErin M SchikowskiRichard H ZouNasreen KhalilVeronica MarcouxDeborah AssayagHélène ManganasJolene H FisherMartin R J KolbKevin F GibsonDaniel J KassYingze ZhangKathleen Oare LindellS Mehdi NouraiePublished in: American journal of respiratory and critical care medicine (2021)
Patients with fILD who live in areas with greater neighborhood-level disadvantage in the U.S. experience higher mortality, and patients with IPF experience lower odds of lung transplant. These disparities are not seen in Canadian patients, which may indicate differences in access to care between the U.S. and Canada.
Keyphrases
- interstitial lung disease
- idiopathic pulmonary fibrosis
- systemic sclerosis
- end stage renal disease
- physical activity
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- rheumatoid arthritis
- cardiovascular events
- palliative care
- prognostic factors
- peritoneal dialysis
- type diabetes
- affordable care act
- patient reported outcomes
- quality improvement
- health insurance
- patient reported